Could giving heart drug earlier save more lives?
NCT ID NCT06680869
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether giving the heart medication amiodarone one cycle earlier than usual during cardiac arrest can improve survival. About 585 adults with a shockable heart rhythm will be enrolled. The goal is to see if this change in timing helps restore a normal heartbeat faster.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Amiodarone (a heart rhythm medication)
- What this could lead to
- If successful, this could lead to a faster, more effective treatment protocol for cardiac arrest, potentially improving survival and recovery.
- What could go wrong
- This is a pilot study, so results are preliminary. The earlier dosing may not improve outcomes and could carry risks like low blood pressure or allergic reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC ARREST are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Oregon Health & Sciences University
RECRUITINGPortland, Oregon, 97035, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can cooling after cardiac arrest change how the body burns fuel?
- Double shocks: could two defibrillators save more cardiac arrest patients?
- Could a smarter breathing machine boost survival after cardiac arrest?
- Balloon in the aorta could boost CPR success in cardiac arrest
- Can an education program ease caregiver trauma after a Child's cardiac arrest?
- Brain rescue: dual drug attack on Post-Arrest seizures shows promise